AUGX

Augmedix (AUGX)

Augmedix Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AUGX

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/14	05 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AUGX	Augmedix Inc
2024/05/14	05 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AUGX	Augmedix Inc
2024/05/14	05 : 03	GlobeNewswire Inc.	Augmedix Delivers 40% Revenue Growth for First Quarter of 2024	NASDAQ:AUGX	Augmedix Inc
2024/05/03	20 : 00	GlobeNewswire Inc.	Augmedix to Participate in Upcoming Investor Conferences in May and June 2024	NASDAQ:AUGX	Augmedix Inc
2024/04/30	20 : 00	GlobeNewswire Inc.	Augmedix to Announce First Quarter 2024 Financial Results on May 13, 2024	NASDAQ:AUGX	Augmedix Inc
2024/04/26	05 : 05	GlobeNewswire Inc.	Augmedix Awarded on Newsweek’s World’s Best Digital Health Companies 2024 List	NASDAQ:AUGX	Augmedix Inc
2024/04/24	20 : 00	GlobeNewswire Inc.	Augmedix Launches Industry’s First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency Departments	NASDAQ:AUGX	Augmedix Inc
2024/04/09	20 : 00	GlobeNewswire Inc.	Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual Care	NASDAQ:AUGX	Augmedix Inc
2024/04/04	20 : 00	GlobeNewswire Inc.	Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems Nationwide	NASDAQ:AUGX	Augmedix Inc
2024/03/19	20 : 33	IH Market News	Unilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and More	NASDAQ:AUGX	Augmedix Inc
2024/03/19	05 : 01	GlobeNewswire Inc.	Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023	NASDAQ:AUGX	Augmedix Inc
2024/03/12	20 : 00	GlobeNewswire Inc.	Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix Go	NASDAQ:AUGX	Augmedix Inc
2024/03/08	21 : 00	GlobeNewswire Inc.	Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024	NASDAQ:AUGX	Augmedix Inc
2024/03/05	10 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc
2024/02/28	10 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc
2024/02/28	10 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc
2024/02/28	10 : 32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc
2024/02/28	10 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc
2024/02/28	10 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc
2024/02/28	10 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc
2024/02/27	21 : 00	GlobeNewswire Inc.	Augmedix to Participate in Citizens JMP Technology Conference	NASDAQ:AUGX	Augmedix Inc
2024/02/13	21 : 00	GlobeNewswire Inc.	Augmedix Names Tomer Levy as New Senior Vice President of Engineering	NASDAQ:AUGX	Augmedix Inc
2024/02/10	04 : 14	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:AUGX	Augmedix Inc
2024/01/23	06 : 15	GlobeNewswire Inc.	Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET	NASDAQ:AUGX	Augmedix Inc
2024/01/16	21 : 00	GlobeNewswire Inc.	Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor Conference	NASDAQ:AUGX	Augmedix Inc
2024/01/10	06 : 14	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc
2024/01/10	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AUGX	Augmedix Inc
2024/01/06	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AUGX	Augmedix Inc
2024/01/05	22 : 00	GlobeNewswire Inc.	Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue	NASDAQ:AUGX	Augmedix Inc
2023/12/20	11 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AUGX	Augmedix Inc